References
- Chee SN, Murrel DF. 2015. Using intravenous immunoglobulins in autoimmune bullous diseases. In: Murrel DF, editor. Blistering diseases: clinical features, pathogenesis, treatment. Berlin Heidelberg: Springer-Verlag. p. 515–520.
- Czernik A, Toosi S, Bystryn JC, Grando SA. 2012. Intravenous immunoglobulin in the treatment of autoimmune bullous dermatoses: an update. Autoimmunity 45:111–118.
- Doiron P, Pratt M. 2010. Antepartum intravenous immunoglobulin therapy in refractory pemphigoid gestationis: case report and literature review. Journal Cutaneous Medical Surgery 14:189–192.
- Gan DCC, Welsh B, Webster M. 2012. Successful treatment of a severe persistent case of pemphigoid gestationis with antepartum and postpartum intravenous immunoglobulin followed by azathioprine. Australasian Journal of Dermatology 53:66–69.
- Ko BJ, Whang KU. 2014. Intravenous immuoglobulin therapy for persistent phempigoid gestationis with steroid induced iatrogenic Cushinǵs syndrome. Annals of Dermatology 5:661–663.
- Kreuter A, Harati A, Breuckman F, Appelhans C, Altmeyer P. 2004. Intravenous immune globulin in the treatment of persistent pemphigoid gestationis. Journal of American Academy of Dermatology 51:1027–1028.
- Rodrigues CDS, Filipe P, Solana MDM, Soares de AL, Cirne de Castro J, Gomes MM. 2007. Persistent herpes gestationis treated with high-dose intravenous immunoglobulin. Acta Dermato-Venereologica 87:184–186.
- Shornick JK, Bangert JL, Freeman RG, Gilliam JN. 1983. Herpes gestationis: clinical and histological features of twenty-eight cases. Journal of American Academy of Dermatology 8:214–224.
- Shornick JK, Black MM. 1992. Fetal risks in herpes gestationis. Journal of American Academy of Dermatology 26:63–68.